Q3 2013

Source filing unavailable

Q3 2013 · —

Revenue

$2.27B

+4.2% vs Q3 2012

Net Income

$27.97M

+13.7% vs Q3 2012

EPS Diluted

$0.44

+12.8% vs Q3 2012

Gross Profit$273,329,000+19.8%

Operating Income$49,215,000+5.5%

Operating Cash Flowderived

Same quarter

Metric	Q3 2013	Q3 2012	Q3 2011	Q3 2010
Revenue	$2.27B	$2.18B	$2.18B	$2.06B
Net Income	$27.97M	$24.60M	$33.35M	$31.51M
EPS Diluted	$0.44	$0.39	$0.53	$0.50

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR